Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.55 |
| ▸ | RAB9A | P51151 | 5/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25341219 | 0.95 | NPC1 (0.50) | NPC1RAB9ANAAALMNAPOLB | |
| SCHEMBL6135253 | 0.94 | NPC1 (0.61) | NPC1RAB9ANAAALMNAPOLB | |
| SCHEMBL15768755 | 0.92 | LMNA (0.49) | NPC1RAB9ANAAALMNAPOLB | |
| SCHEMBL15768756 | 0.92 | LMNA (0.49) | NPC1RAB9ANAAALMNAPOLB | |
| SCHEMBL28063078 | 0.91 | NAAA (0.64) | NPC1RAB9ANAAALMNAPOLB | |
| SCHEMBL31174260 | 0.91 | SMN1; SMN2 (0.55) | NPC1RAB9ANAAAPOLBHPGD | |
| SCHEMBL16670767 | 0.91 | SMN1; SMN2 (0.55) | NPC1RAB9ANAAAPOLBHPGD | |
| SCHEMBL20025770 | 0.89 | NAAA (0.54) | NPC1RAB9ANAAALMNAPOLB | |
| SCHEMBL28530862 | 0.88 | TSHR (0.48) | NPC1RAB9ANAAALMNAPOLB | |
| SCHEMBL22373760 | 0.88 | LMNA (0.62) | NPC1RAB9ANAAALMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 612 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605695-B2 | Molecularly imprinted fluorescent polymers for direct detection of glyphosate, its degradation products, and metabolites | BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VERTRETEN DURCH DEN PRÄSIDENTEN DER BUNDESANSTALT FÜR MATERIALFORSCHUNG UND -PRÜFUNG, (BAM) (DE) | 2026-04-21 | — | — | US | claimed |
| US-20260098225-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | SURMODICS INC (US) | 2026-04-09 | — | — | US | claimed |
| WO-2025198684-A9 | BaTiO3 NANOCRYSTALS AND NANOCOMPOSITES | PIXELLIGENT TECHNOLOGIES LLC (US) | 2025-11-27 | — | — | WO | claimed |
| EP-4615530-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | SurModics, Inc. (US) | 2025-09-17 | — | — | EP | claimed |
| US-20250230334-A1 | SOLVENT-FREE FORMULATIONS AND NANOCOMPOSITES | PT SPE SUBCO LLC (US) | 2025-07-17 | — | — | US | claimed |
| CN-120114655-A | Delivery of hydrophobic active agent particles | 苏尔莫迪克斯公司 | 2025-06-10 | — | — | CN | claimed |
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | claimed |
| EP-4514346-A1 | MEDICAL DEVICE COATINGS WITH MICROCRYSTALLINE ACTIVE AGENTS | SurModics, Inc. (US) | 2025-03-05 | — | — | EP | claimed |
| EP-4489804-A1 | THROMBORESISTANT COATINGS, COATED DEVICES, AND METHODS | Surmodics Coatings, LLC (US) | 2025-01-15 | — | — | EP | claimed |
| US-20240342345-A1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | BANK OF MONTREAL, AS COLLATERAL AGENT | 2024-10-17 | — | — | US | claimed |
| US-20030099949-A1 | Arrays having clustered arrangements and methods of making and using | SURMODICS, INC. | 2003-05-29 | — | — | US | claimed |
| EP-1309360-A2 | MEDICAMENT INCORPORATION MATRIX | SurModics, Inc. (US) | 2003-05-14 | — | — | EP | claimed |
| WO-2003031054-A2 | ARRAYS HAVING CLUSTERED ARRANGEMENTS AND METHODS OF MAKING AND USING THEM | SURMODICS, INC. (US) | 2003-04-17 | — | — | WO | claimed |
| US-20030073086-A1 | Randomly ordered arrays and methods of making and using | SURMODICS, INC. | 2003-04-17 | — | — | US | claimed |
| WO-2003031979-A1 | RANDOMLY ORDERED ARRAYS AND METHODS OF MAKING AND USING | SURMODICS, INC. (US) | 2003-04-17 | — | — | WO | claimed |
| US-6506895-B2 | Oligonucleotide for use in generation of nucleic acid chips | SURMODICS, INC. | 2003-01-14 | — | — | US | claimed |
| US-20020041899-A1 | Medicament incorporation matrix | Surmodics Coatings, LLC | 2002-04-11 | — | — | US | claimed |
| WO-2002013871-A2 | MEDICAMENT INCORPORATION MATRIX | SURMODICS, INC. (US) | 2002-02-21 | — | — | WO | claimed |
| EP-1069916-A2 | LATENT REACTIVE BLOOD COMPATIBLE AGENTS | SurModics, Inc. (US) | 2001-01-24 | — | — | EP | claimed |
| WO-1999047176-A2 | LATENT REACTIVE BLOOD COMPATIBLE AGENTS | SURMODICS, INC. (US) | 1999-09-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605695-B2 | Molecularly imprinted fluorescent polymers for direct detection of glyphosate, its degradation products, and metabolites | GRIN3A, PAM, GYPA | NPC1 3549/4885RAB9A 3423/4885NAAA 175/4885 |
| US-20260098225-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | CUTA, EED, SELP | NPC1 4807/4885RAB9A 3018/4885NAAA 2045/4885 |
| US-20020041899-A1 | Medicament incorporation matrix | COL14A1, MATR3, ECPAS | NPC1 4799/4885RAB9A 4877/4885NAAA 1455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.